医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

World’s First Portable Fingerprint Drug Test Now Available in Australia and New Zealand

2018年03月15日 AM07:00
このエントリーをはてなブックマークに追加


 

LONDON & MELBOURNE

The world’s first portable fingerprint-based drug test – which works by analysing sweat from a fingerprint to determine if someone has recently used cocaine, opiates, amphetamines or cannabis – is now available in Australia and New Zealand following a new distribution agreement. Unlike traditional urine or saliva-based drug testing, fingerprint testing is non-invasive, fast and cost-effective – making it an ideal solution to support drug testing programmes within drug rehabilitation, workplace and criminal justice arenas for example.

Melbourne-based Henley Health – an established distributor of drug testing solutions, with a proven track record in launching disruptive technologies – has been appointed as the first Asia Pacific region partner for the revolutionary Intelligent Fingerprinting Drug Screening System. Designed and manufactured in the UK, the fingerprint drug test is the result of several years of intense R&D and over £10 million of development funding. Fingerprint sample collection takes only five seconds, with simultaneous screening results for all four drug groups provided in just eight minutes.

According to Kevin Walsh, Executive Director at Henley Health Pty Ltd: “drug testing, especially when it involves the collection of body fluid samples, is invariably costly, time-consuming and challenging to administer. Existing methods can also be intrusive or undignified for both the person being tested and the sample collector. That’s why we’re excited about the Intelligent Fingerprinting Drug Screening System because it’s so quick and easy to implement wherever and whenever it’s needed. We see fingerprint-based drug testing as a valuable addition to Henley Health’s existing suite of products as it gives us a particularly versatile and effective means of supporting our customers’ drug screening requirements.”

An introductory video demonstrating the fingerprint-based drug testing in action is available here.

More information on this story and imagery here

About Intelligent Fingerprinting

Launched in August 2017, Intelligent Fingerprinting’s portable Drug Screening System works by analysing the sweat from a fingerprint sample. It is non-invasive, fast and cost-effective – screening for multiple drug groups simultaneously (currently amphetamines, cannabis, cocaine and opiates) with sample collection taking 5 seconds and results in minutes. A laboratory confirmation service is also available. www.intelligentfingerprinting.com Twitter @iFingerprinting

View source version on businesswire.com: http://www.businesswire.com/news/home/20180314006102/en/

CONTACT

Comma
Cheryl Billson, +44 (0)7791 720460
cheryl.billson@commacomms.com
or
Intelligent
Fingerprinting

Henley Health, +61 3 9097 1810

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Takeda Announces Information Related to its Pending Voluntary and Conditional Public Takeover Bid for Outstanding Shares and American Depositary Shares of TiGenix
  • Prota/MCRI Completes Enrolment of Phase 2b Multicentre Clinical Trial of Probiotic Oral Immunotherapy for the Treatment of Peanut Allergy (PPOIT-003)
  • Dr. Reddy’s Q4 and FY18 Financial Results
  • 武田薬品が米国臨床腫瘍学会(ASCO)と欧州血液学会(EHA)の年次総会でオンコロジーの広範なポートフォリオとパイプラインのデータを発表
  • ResMed赞助的研究显示,采用居家吸氧与居家无创通气相结合治疗COPD具有成本效益